Pathos AI, Inc., a New York City-based AI drug discovery company, raised $237 million in a Series E fundraising round led by Bristol Myers Squibb.
More on STAT+ →
Pathos AI, Inc., a New York City-based AI drug discovery company, raised $237 million in a Series E fundraising round led by Bristol Myers Squibb.
More on STAT+ →
PONGBOT, a Shanghai-based sports-training robot maker, raised hundreds of...
Swamp Club, a San Francisco-based early-stage technology startup, raised...
Opply, a London-based AI procurement automation platform, raised $7.5...
Tolan, a San Francisco-based stealth software company, raised $30 million...
CarbonAI, a New York-based agentic AI for CRE lending, raised $12 million...
WarpWare, a Broomfield, CO-based agentic flight software tools company,...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.